Acera Surgical has raised $5.1 million in a new round of equity financing, according to a recently posted SEC filing.
The St. Louis-based company is developing an implantable nanomedical scaffold intended for medical applications including soft tissue repair, according to a St. Louis Business Journal report. Acera also produces a protective wound cover called Restrata.
Acera licensed the surgical mesh technology behind their products from the Washington University Office of Technology Management in 2012, according to the article.
A total of two anonymous investors have joined in the round, with the first sale dated on October 5, according to the SEC filing.
The company is looking to raise an additional $5 million in the round, bringing the total raised up to $10.1 million.
Acera has not yet stated how it plans to spend funds raised in the round.
